Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on Tuesday, September 9, 2025. Thomas Zindrick, President, CEO and Chairman of the Board, along with Matt Pulisic, Chief Financial Officer, will represent the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genelux Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9518919-en) on September 02, 2025, and is solely responsible for the information contained therein.
Comments